These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38797150)

  • 1. Novel structure of the anti-CRISPR protein AcrIE3 and its implication on the CRISPR-Cas inhibition.
    Kim DY; Han JH; Lee SY; Ha HJ; Park HH
    Biochem Biophys Res Commun; 2024 Aug; 722():150164. PubMed ID: 38797150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 1.3 Å high-resolution crystal structure of an anti-CRISPR protein, AcrI E2.
    Lee SY; Kim GE; Kim YG; Park HH
    Biochem Biophys Res Commun; 2020 Dec; 533(4):751-757. PubMed ID: 32988588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR RNA and anti-CRISPR protein binding to the
    Hong S; Ka D; Yoon SJ; Suh N; Jeong M; Suh JY; Bae E
    J Biol Chem; 2018 Feb; 293(8):2744-2754. PubMed ID: 29348170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A high-resolution (1.2 Å) crystal structure of the anti-CRISPR protein AcrIF9.
    Kim GE; Lee SY; Park HH
    FEBS Open Bio; 2020 Dec; 10(12):2532-2540. PubMed ID: 32990416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-resolution crystal structure of the anti-CRISPR protein AcrIC5.
    Kang YJ; Park HH
    Biochem Biophys Res Commun; 2022 Oct; 625():102-108. PubMed ID: 35952606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis of transcriptional repression of anti-CRISPR by anti-CRISPR-associated 2.
    Lee SY; Kim GE; Park HH
    Acta Crystallogr D Struct Biol; 2022 Jan; 78(Pt 1):59-68. PubMed ID: 34981762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition Mechanism of an Anti-CRISPR Suppressor AcrIIA4 Targeting SpyCas9.
    Yang H; Patel DJ
    Mol Cell; 2017 Jul; 67(1):117-127.e5. PubMed ID: 28602637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disabling a Type I-E CRISPR-Cas Nuclease with a Bacteriophage-Encoded Anti-CRISPR Protein.
    Pawluk A; Shah M; Mejdani M; Calmettes C; Moraes TF; Davidson AR; Maxwell KL
    mBio; 2017 Dec; 8(6):. PubMed ID: 29233895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular insights into DNA interference by CRISPR-associated nuclease-helicase Cas3.
    Gong B; Shin M; Sun J; Jung CH; Bolt EL; van der Oost J; Kim JS
    Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16359-64. PubMed ID: 25368186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based functional mechanisms and biotechnology applications of anti-CRISPR proteins.
    Jia N; Patel DJ
    Nat Rev Mol Cell Biol; 2021 Aug; 22(8):563-579. PubMed ID: 34089013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural insights into the inactivation of the type I-F CRISPR-Cas system by anti-CRISPR proteins.
    Yang L; Zhang Y; Yin P; Feng Y
    RNA Biol; 2021 Nov; 18(sup2):562-573. PubMed ID: 34606423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of the anti-CRISPR, AcrIIC4.
    Kim GE; Lee SY; Park HH
    Protein Sci; 2021 Dec; 30(12):2474-2481. PubMed ID: 34676610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-CRISPR AcrIE2 Binds the Type I-E CRISPR-Cas Complex But Does Not Block DNA Binding.
    Mejdani M; Pawluk A; Maxwell KL; Davidson AR
    J Mol Biol; 2021 Feb; 433(3):166759. PubMed ID: 33338493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The crystal structure of Cpf1 in complex with CRISPR RNA.
    Dong D; Ren K; Qiu X; Zheng J; Guo M; Guan X; Liu H; Li N; Zhang B; Yang D; Ma C; Wang S; Wu D; Ma Y; Fan S; Wang J; Gao N; Huang Z
    Nature; 2016 Apr; 532(7600):522-6. PubMed ID: 27096363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal Structure of Streptococcus pyogenes Cas1 and Its Interaction with Csn2 in the Type II CRISPR-Cas System.
    Ka D; Lee H; Jung YD; Kim K; Seok C; Suh N; Bae E
    Structure; 2016 Jan; 24(1):70-79. PubMed ID: 26671707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for inhibition of the type I-F CRISPR-Cas surveillance complex by AcrIF4, AcrIF7 and AcrIF14.
    Gabel C; Li Z; Zhang H; Chang L
    Nucleic Acids Res; 2021 Jan; 49(1):584-594. PubMed ID: 33332569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and mechanistic insights into the CRISPR inhibition of AcrIF7.
    Kim I; Koo J; An SY; Hong S; Ka D; Kim EH; Bae E; Suh JY
    Nucleic Acids Res; 2020 Sep; 48(17):9959-9968. PubMed ID: 32810226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for dimer formation of the CRISPR-associated protein Csm2 of Thermotoga maritima.
    Gallo G; Augusto G; Rangel G; Zelanis A; Mori MA; Campos CB; Würtele M
    FEBS J; 2016 Feb; 283(4):694-703. PubMed ID: 26663887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural Variation of Type I-F CRISPR RNA Guided DNA Surveillance.
    Pausch P; Müller-Esparza H; Gleditzsch D; Altegoer F; Randau L; Bange G
    Mol Cell; 2017 Aug; 67(4):622-632.e4. PubMed ID: 28781236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural plasticity and in vivo activity of Cas1 from the type I-F CRISPR-Cas system.
    Wilkinson ME; Nakatani Y; Staals RH; Kieper SN; Opel-Reading HK; McKenzie RE; Fineran PC; Krause KL
    Biochem J; 2016 Apr; 473(8):1063-72. PubMed ID: 26929403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.